-
Product Insights
Vulvovaginal Candidiasis – Drugs In Development, 2023
Global Markets Direct’s, ‘Vulvovaginal Candidiasis - Drugs In Development, 2023’, provides an overview of the Vulvovaginal Candidiasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vulvovaginal Candidiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Systemic Candidiasis – Drugs In Development, 2023
Global Markets Direct’s, ‘Systemic Candidiasis - Drugs In Development, 2023’, provides an overview of the Systemic Candidiasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Systemic Candidiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Candidiasis – Drugs In Development, 2023
Global Markets Direct’s, ‘Candidiasis - Drugs In Development, 2023’, provides an overview of the Candidiasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Candidiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Mycoses – Drugs In Development, 2023
Global Markets Direct’s, ‘Mycoses - Drugs In Development, 2023’, provides an overview of the Mycoses pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mycoses, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Implantable Cardioverter Defibrillators (ICD) – Medtronic Plc – CONCERTO
GlobalData, the industry analysis specialist, has released its latest report: Implantable Cardioverter Defibrillators (ICD) - Medtronic Plc - CONCERTO. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
-
Product Insights
Renal Dialysis Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Renal Dialysis Equipment Pipeline Market Report Overview Renal dialysis equipment is intended to provide an artificial replacement for lost kidney function due to renal failure. Dialysis machines, dialysis accessories, vascular access devices for hemodialysis, and stone management disposables are covered in this category. The renal dialysis equipment pipeline market research report provides comprehensive information about the renal dialysis equipment pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Company Insights
Pfizer Inc – Digital Transformation Strategies
Pfizer Inc Digital Transformation Strategies Overview Pfizer uses AI and data analytics to accelerate drug discovery and enhance operational efficiencies as a part of its digital transformation strategies. The annual ICT spending of Pfizer was estimated at $3.6 billion in 2022. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. Pfizer Inc (Pfizer) discovers, develops, manufactures, and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic and...
-
Company Insights
Johnson and Johnson – Enterprise Tech Ecosystem Series
Johnson and Johnson has been strategically focusing on disruptive technologies such as AI & Machine Learning, Robotics, IoT, and Digital Therapeutics among various others to digitally transform legacy practices in business. The company has been focused on leveraging digital manufacturing techniques using 3D printing. J&J key accelerators, incubators, & other innovation programs include Janssen Business Development, JLABS, Janssen Disease Interception Accelerator (DIA), and JLINX among others. The company's investment portfolio comprises of Cala Health, BlackThorn, Zebra Medical Vision, Cara Care,...